Healthcare
Coeptis Therapeutics Holdings, Inc.(COEPW)
Live Price
Offline$0.0104
+0.00% today
Window Change
-58.59%
Window
Jun 25, 2025 → Apr 24, 2026
- Market Cap
- $64.72K
- Revenue Growth
- 0.0%
- EPS Growth
- +50.3%
- Dividend Yield
- 0.0%
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 188 bars · Jun 25, 2025 → Apr 24, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Coeptis Therapeutics Holdings, Inc. (COEPW) is a Healthcare stock with a market cap of $64.72K and listed on NASDAQ. The stock last traded around $0.01 and down 58.6% across the available one-year price window (Jun 25, 2025 → Apr 24, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +50.3%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +50.3%, free cash flow -29.4% with operating margin -956.9% and ROIC -55.7%. Valuation already assumes a fairly strong business story at price/sales 42.3. Stock Foundry combines COEPW price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +7.6% peer median
Operating Margin
Below sector median
-956.9% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The setup is mixed rather than one-directional
Revenue is 0.0% and EPS is +50.3%, while operating margin sits near -956.9%.
Benchmark Edge
COEPW vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
COEPW
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
COEPW Max Drawdown
-78.90%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for COEPW and SPY.
Company Overview
Coeptis Therapeutics Holdings, Inc.
NASDAQ
Bull Horn Holdings Corp. was a special purpose acquisition company (SPAC) that operated with the primary goal of effecting mergers, capital stock exchanges, asset acquisitions, stock purchases, reorganizations, or similar business combinations. Established in 2018 and based in Miami Beach, Florida, Bull Horn Holdings Corp. initially focused its search on targets within the sports, entertainment, and brand sectors, leveraging its management experience to identify and facilitate strategic business opportunities. In October 2022, Bull Horn Holdings Corp. completed a business combination with Coeptis Therapeutics, Inc., a biopharmaceutical firm specializing in cell therapy platforms for cancer. Following this transaction, Bull Horn Holdings Corp. ceased to exist as an independent entity, and Coeptis Therapeutics Holdings, Inc. became the surviving company, now listed on the Nasdaq Global Market. Throughout its lifecycle, Bull Horn Holdings Corp. exemplified the SPAC model’s role in providing alternative pathways for private companies to access public markets and scale their operations.
- Region
- United States
- Last Updated
- May 8, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- —
- EV/EBITDA
- —
- Price/Sales
- 42.3
- Price/Book
- 4.0
Growth
- Revenue
- 0.0%
- EPS
- +50.3%
- Free Cash Flow
- -29.4%
Profitability
- Gross Margin
- -207.8%
- Operating Margin
- -956.9%
- Net Margin
- -611.1%
- ROE
- -78.8%
- ROIC
- -55.7%
Balance Sheet
- Debt/Equity
- 0.02
- Current Ratio
- 4.16
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.